TY - JOUR
T1 - Diagnostic workup for postmenopausal bleeding: a randomised controlled trial
T2 - a randomised controlled trial
AU - van Hanegem, N.
AU - Breijer, M. C.
AU - Slockers, S. A.
AU - Zafarmand, M. H.
AU - Geomini, P. M. A. J.
AU - Catshoek, R.
AU - Pijnenborg, J. M. A.
AU - van der Voet, L. F.
AU - Dijkhuizen, F. P. H. L. J.
AU - van Hoecke, G. C. R.
AU - Reesink-Peters, N.
AU - Veersema, S.
AU - van Hooff, M. H. A.
AU - van Kesteren, P. J. M.
AU - Huirne, J. A.
AU - Opmeer, B. C.
AU - Bongers, M. Y.
AU - Mol, B. W. J.
AU - Timmermans, A.
PY - 2017/1
Y1 - 2017/1
N2 - To evaluate the effectiveness of hysteroscopy for the detection and treatment of endometrial polyps versus expectant management in women with postmenopausal bleeding (PMB), a thickened endometrium and benign endometrial sampling. Multicentre, randomised controlled trial. Three academic hospitals and nine non-academic teaching hospitals in the Netherlands. Women with PMB, an endometrial thickness >4 mm and benign result from endometrial sampling. Women were randomised to either further diagnostic workup by hysteroscopy (preceded by saline infusion sonography) or expectant management. The primary outcome measure was recurrence of PMB within a year after randomisation. Secondary outcome measures were time to recurrent bleeding and recurrent bleeding after more than 1 year. In the hysteroscopy group, the presence of polyps and the results of their histology were registered. Between January 2010 and October 2013, 200 women were randomised; 98 to hysteroscopy and 102 to expectant management. Within 1 year a total of 15 women (15.3%) in the hysteroscopy group experienced recurrent bleeding, versus 18 (18.0%) in the expectant management group (relative risk 0.85 (95% CI 0.46-1.59). In the hysteroscopy group, 50/98 (51%) polyps were diagnosed of which 6/98 (6%) showed evidence of endometrial (pre)malignancy; final pathology results after hysterectomy showed three women with hyperplasia with atypia and three women with endometrial cancer. In women with PMB, a thickened endometrium and benign endometrial sampling, operative hysteroscopy does not reduce recurrent bleeding. Hysteroscopy detected focal endometrial (pre)malignancy in 6% of women who had benign endometrial sampling. This finding indicates that in these women, further diagnostic workup is warranted to detect focal (pre)malignancies, missed by blind endometrial sampling. In women with PMB, hysteroscopy does not reduce recurrent bleeding but is warranted to detect focal malignancy
AB - To evaluate the effectiveness of hysteroscopy for the detection and treatment of endometrial polyps versus expectant management in women with postmenopausal bleeding (PMB), a thickened endometrium and benign endometrial sampling. Multicentre, randomised controlled trial. Three academic hospitals and nine non-academic teaching hospitals in the Netherlands. Women with PMB, an endometrial thickness >4 mm and benign result from endometrial sampling. Women were randomised to either further diagnostic workup by hysteroscopy (preceded by saline infusion sonography) or expectant management. The primary outcome measure was recurrence of PMB within a year after randomisation. Secondary outcome measures were time to recurrent bleeding and recurrent bleeding after more than 1 year. In the hysteroscopy group, the presence of polyps and the results of their histology were registered. Between January 2010 and October 2013, 200 women were randomised; 98 to hysteroscopy and 102 to expectant management. Within 1 year a total of 15 women (15.3%) in the hysteroscopy group experienced recurrent bleeding, versus 18 (18.0%) in the expectant management group (relative risk 0.85 (95% CI 0.46-1.59). In the hysteroscopy group, 50/98 (51%) polyps were diagnosed of which 6/98 (6%) showed evidence of endometrial (pre)malignancy; final pathology results after hysterectomy showed three women with hyperplasia with atypia and three women with endometrial cancer. In women with PMB, a thickened endometrium and benign endometrial sampling, operative hysteroscopy does not reduce recurrent bleeding. Hysteroscopy detected focal endometrial (pre)malignancy in 6% of women who had benign endometrial sampling. This finding indicates that in these women, further diagnostic workup is warranted to detect focal (pre)malignancies, missed by blind endometrial sampling. In women with PMB, hysteroscopy does not reduce recurrent bleeding but is warranted to detect focal malignancy
KW - Journal Article
U2 - https://doi.org/10.1111/1471-0528.14126
DO - https://doi.org/10.1111/1471-0528.14126
M3 - Article
C2 - 27225535
SN - 1470-0328
VL - 124
SP - 231
EP - 240
JO - BJOG
JF - BJOG
IS - 2
ER -